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Background.Ourobjectivewastoevaluateendothelialfunctionandmarkersofinﬂammationduringandafterpregnancyinnormal
pregnancies compared to pregnancies complicated with hypertension or preeclampsia (PE). Methods and Results. We measured
endothelium-dependent brachial artery ﬂow-mediated vasodilation (FMD) and high sensitive C-reactive protein (hsCRP),
interleukin-6 (IL-6), and tumour necrosis factor-α (TNF-α) in 32 women with normal pregnancy and in 28 women whose
pregnancy was complicated with hypertensive disorder in the second half of pregnancy and minimum 3-month postpartum. En-
hancement of endothelial function was greater in hypertensive than normal pregnancies, the mean FMD% being 11.0% versus
8.8% during pregnancy (P = 0.194) and 8.0% versus 7.9% postpartum (P = 0.978). Concentrations of markers of inﬂammation
were markedly increased in pregnant hypertensive group compared to those after delivery (hsCRP 4.5 versus 0.80mg/L, P = 0.023,
IL-6 2.1 versus 1.2pg/mL, P = 0.006; TNF-α 1.9 versus 1.5pg/mL, P = 0.030). There were no statistically signiﬁcant associations
betweenthemarkersofinﬂammationandFMD.Conclusions.BrachialarteryFMDwasnotattenuatedinthethirdtrimesterhyper-
tensive pregnancies compared to normal pregnancies, whereas circulating concentrations of hsCRP and IL-6 and TNF-α reacted
to hypertensive complications.
1.Introduction
Assessment of ﬂow-mediated dilatation (FMD) in cardiovas-
cular disease gives information on endothelial function and
predicts cardiovascular morbidity and even cardiovascular
death [1]. During normal pregnancy endothelial function
improves due to increase in nitric oxide (NO) bioavailability
[2–4]. Healthy endothelium not only mediates endothelium-
dependent vasodilation, but also actively suppresses throm-
bosis, vascular inﬂammation, and hypertrophy [5]. In pree-
clampsia-impaired trophoblast invasion and diﬀerentiation
lead to placental ischemia and increased release of antiangi-
ogenic factors [6]. Endothelial dysfunction, in turn, leads to
mild to severe hypertension, oedema and proteinuria, and
ischemic changes in several organs, in particular in kidneys
[6]. Despite many advances in our understanding of the pa-
thophysiology of preeclampsia, delivery of the placenta re-
mains the only deﬁnitive treatment. According to WHO
more than 40000 women die of pregnancy-induced hyper-
tensive disorder per year [7]. Although signs and symptoms
of preeclampsia, with the exception of hypertension in a
smallnumberofwomen,recovertheriskofprematurecardi-
ovascular diseases is 2–7-fold higher after maternal placental
syndrome than after a normal pregnancy [8].
Endothelial function has been assessed mostly by FMD,
based on the assumption that impaired FMD reﬂects not
only impaired dilatation but also other alterations of endo-
thelial function [5]. In preeclampsia attenuated FMD has
been assumed to predict the clinical disease about 10 weeks
before the actual signs and symptoms [9]. We wanted to2 ISRN Obstetrics and Gynecology
evaluate whether the assessment of FMD is clinically relevant
in hypertensive pregnancies and preeclampsia and how
recovery takes place after delivery.
2.MaterialsandMethods
We prospectively examined a total of 60 women: 32 normal
pregnant women and 12 preeclamptic and 16 hypertensive
women in the third trimester of pregnancy and minimum
three-month postpartum. Postpartum, we could reach 75%
of the normal pregnancies and 61.5% of the hypertensive
group.Smokerswereexcluded.Thepatientswererecruitedin
the Kuopio University Hospital Maternity clinic or maternity
ward through years 2002–2006. The local Ethics Committee
approved the study and the patients gave written informed
consent.
Weight in the beginning of pregnancy and height were
collected from medical records and BMI was calculated.
Blood pressure was measured at nurse’s oﬃce from right arm
after 15 minutes of rest with an automatic device. The mean
of the three measurements was calculated for each patient.
Continuous blood pressure recording was performed from
the middle ﬁnger of the right hand. All recordings and data
analyseswereperformedwithanIBMPC-compatiblemicro-
computer with a commercial WINACQ/WINCPRS acqui-
sition electronics and software (Absolute Aliens Oy, Turku,
Finland), which includes a sophisticated analysis program
designed for research of cardiovascular physiology.
Body composition was determined by bioimpedance
analysis (InBody 3.0, BioSpace Co., LTD., Seoul, Republic of
Korea). The device used 8-point tactile electrodes; two were
in contact with the palm and thumb of each hand and two
with anterior and posterior aspects of the soles of the feet.
The measurement was performed for undressed subjects in
upright position, the soles in contact with the foot electrodes
and the hands grabbing the hand electrodes. The electrodes
wereconnectedtothevoltageandpowersupplyofthedevice.
The device used segmental multifrequency measurement
method. The total body was measured in ﬁve segments, up-
per and lower extremities and trunk, and microprocessor
controlled coupling of the electrodes. The multifrequency
measurement was conducted by using multiple frequencies
at 5, 50, 250, and 500kHz for each electrode coupling.
From the device report, intracellular and extracellular ﬂuid
volume, fat mass, percentage body fat (fat-%), and lean body
mass were used. The measurements were performed during
thethirdtrimesterofpregnancyandthree-monthafterdeliv-
ery at least two hours after ingestion of a light breakfast and
after voiding the urinary bladder before the measurement.
Fastingbloodsamplesweredrawnfromeachsubjectdur-
ing pregnancy and three months postpartum. Venous blood
samples were drawn from the right antecubital vein of re-
cumbent subjects after a 12-hour overnight fast for determi-
nation of serum hsCRP, TNF-α, and IL-6, and serum lipids
andlipoproteinconcentrations.Serumwasseparatedbycen-
trifugation and samples were stored frozen (−70◦C) until
analysis. Cholesterol and triglyceride levels were assayed
by standard enzymatic photometric methods with Konelab
60i Clinical Chemistry Analyzer (Thermo Electron Co.,
Finland). Serum samples were analyzed by Immage auto-
mated analyzer using Beckman Coulter High Sensitivity C-
Reactive Protein (CRPH) reagents (Beckman-Coulter, Full-
erton, CA, USA) with working range of 0.2 to 1440mg/L.
Serum samples were analyzed according to the instructions
of the manufacturer.
IL-6 was analyzed by R&D Systems Quantikine HS Hu-
manIL-6ImmunossayKit(Minneapolis,USA)withworking
range of 0.156 to 10pg/mL. Serum samples were analyzed
according to the instructions of the manufacturer. Calibra-
tors (supplied by the manufacturer) were analyzed in dupli-
cate and samples as a single measurements. The absorbance
at 490nm was measured using a microplate reader (Tecan
SPECTRAFluor, Tecan Group Ltd., Maennedorf, Switzer-
land). Serum samples were analyzed by R&D Systems
Quantikine HS Human TNF-α/TNFSF1A Immunossay Kit
(Minneapolis, USA) with working range of 0.5 to 32pg/mL.
Serum samples were analyzed according to the instructions
of the manufacturer. Calibrators (supplied by the manufac-
turer) were analyzed in duplicate and samples as a single
measurements. The absorbance at 490nm was measured
using a microplate reader (Tecan SPECTRAFluor, Tecan
Group Ltd., Maennedorf, Switzerland).
Ultrasound studies were performed using either Sonoace
6000C (Kretz, Marl, Germany) or Sequoia 512 (Acuson,
MountainView,CA,USA)ultrasoundscanner.Toassessbra-
chial FMD, the left brachial artery diameter was measured
both at rest and after reactive hyperaemia. Increased ﬂow
was induced by inﬂation of a pneumatic tourniquet placed
around the forearm to a pressure of 250mmHg for 4.5 min-
utes, followed by release. Three measurements of arterial di-
ameter were performed at end diastole at a ﬁxed distance
from an anatomic marker at rest and at 40, 60, and 80 sec-
onds after cuﬀ release. The vessel diameter in scans after re-
active hyperaemia was expressed both as change in absolute
diameter (FMD) and as the percentage relative to the resting
scan (FMD%). After a 10min wash-out period nitrate (isos-
orbide dinitrate spray 2.5mg, Dinit) was administered per
os. Nitrate related vasodilatation (NTG%) was assessed from
the maximally dilated vessel diameter 3–5min after nitrate
administration relative to vessel diameter at rest before
nitrate administration.
Data are presented as means and medians when appro-
priate. Data normality was examined with Kolmogorov-
Smirnov test. Comparisons between the groups were per-
formed with the Kruskall-Wallis test and the mixed models-
analysis with Bonferroni adjustment for multiple compari-
sons. Univariate correlations were performed using Spear-
man correlation. A computer software program (SPSS 11.5
forwindows;SPSSInc,Chicago,IL,USA)wasused.Aproba-
bility level < 0.05 was considered statistically signiﬁcant.
3. Results
Clinical characteristics of the mothers and outcome of
the neonates are presented in Table 1. The gestational age
and birth weight of the neonates were signiﬁcantly lower
in the hypertensive and preeclampsia group than in the
reference group, whereas the caesarean section rate wasISRN Obstetrics and Gynecology 3
Table 1:Clinicalcharacteristicsofthe60womenexaminedduringpregnancyandneonataloutcomes.Dataispresentedasmeansornumber
of cases (%), minimums, maximums, and standard deviations.
Control, normal
pregnancies
(N = 32)
Hypertensive
pregnancies
(N = 16)
Preeclamptic
pregnancies
(N = 12)
P
(Kruskall-Wallis
test/Chi-square)
Pooled
(N = 28)
P
(Mann-Whitney
U-test)
Age (years) 31
(20–39) ± 4.7
30
(21–41) ± 5.9
32
(25–40) ± 5.3 0.565 31
(21–41) ± 5.6 0.829
Gestational age at
the examination day
34
(24–38) ± 3.26
36
(31–38) ± 1.72
33
(25–39) ± 4.53 0.027 35
(24–39) ± 3.53 0.187
Nulliparous (n/%) 18/56.3% 14/87.5% 5/41.7% 0.031 19/68% 0.356
(Chi-square)
BMI before
pregnancy (kg/m2)
22.9
(18.7−28.6) ±
2.91
24.4
(19.3−33.8) ±
4.00
25.5
(19.7−32.5) ± 3.76 0.112 24.9
(19.3−33.8) ± 3.87 0.069
Gestational age at
birth (weeks)
40 weeks
(38−42) ± 10
days
(1.4 weeks)
37 weeks
(33−39) ± 6d a y s
(0.9 weeks)
39 weeks
(35−40) ± 11 days
(1.5 weeks)
<0.001
38
(33−40) ± 11 days
(1.6 weeks)
<0.001
Birth weight
(grams)
3597
(2360−4700) ±
508
2754
(1775−3620) ±
533
3113
(1975−3960) ± 564 <0.001 2907
(1775−3960) ± 565 <0.001
Caesarean section
(N/%) 5/15.6% 6/37.5% 3/25.0% 0.134 9/32.1% 0.131
(Chi-square)
Apgar at age of 1
minute/ﬁve minutes 9/9 9/9 8/9 0.276/0.831 8/9 0.150/0.370
Blood pressure
109/69
(91−125/57−81)
± 7.53/6.28
136/89
(118−149/81−99)
± 9.47/5.55
130/88
(107−146/64−99) ±
12.7/11.9
<0.001
134/89
(107−149/64−99) ±
11.0/8.70
<0.001
nonsigniﬁcantly increased. The mean age of the mothers,
gestational age, and BMI before pregnancy were similar in
b o t hg r o u p s .S m o k e r sw e r ee x c l u d e d .B l o o dp r e s s u r ew a s
signiﬁcantly elevated in hypertensive group.
Data of the brachial artery ﬂow-mediated vasodilation
are shown in Tables 2(a)–2(c). Endothelial function was
somewhat improved during pregnancy compared to non-
pregnant state, but the change according to improvement of
FMD% was not statistically signiﬁcant. There was no signiﬁ-
cant diﬀerence in FMD between hypertensive pregnancies
and preeclampsia and therefore the groups were pooled.
FMDwasslightlybutnonsigniﬁcantlyhigherinhypertensive
group than in the reference group during pregnancy and
practically equal postpartum.
The concentrations of the hsCRP, IL-6, and TNF-α are
demonstrated in Table 3. All three markers of inﬂammation
were elevated in hypertensive pregnancies compared to the
postpartum situation of the same group. Also in normal
pregnancies hsCRP, IL-6, and TNF-α concentrations were
increased as compared to postpartum levels, but the diﬀer-
ences were less pronounced and nonsigniﬁcant.
During normal pregnancy FMD% was associated nega-
tively especially with brachial artery diameter at rest (R =
−0.623, P<0.001) and in lesser extent with GTN (R =
−0.388, P = 0.028). Maternal weight near term was nega-
tively associated with FMD% (R =− 0.449, P = 0.041).
HDL correlated to the dilation in nitro test. (R = 0.364, P =
0.041). Levels of hsCRP and IL-6 had a positive association,
(R = 0.694, P<0.001) and IL-6 correlated also with
gestational age (R = 0.418, P = 0.021).
3 months after normal pregnancy baseline brachial ar-
tery diameter correlated negatively with FMD% (R =
−0.487, P = 0.016). Dilation in nitro test (endothelium in-
dependent vasodilation) correlated positively with blood
pressure (R = 0.482, P = 0.017). We found no explaining
factors for markers of inﬂammation postpartum.
In the group of hypertensive pregnancies brachial artery
diameter at rest aﬀe c t e dt oG T N %( R =− 0.555, P = 0.004)
and hsCRP (R =− 0.459, P = 0.021), whereas its association
with FMD% was not signiﬁcant (R =− 0.177, P = 0.388).
GTN% was also negatively associated with maternal age
(R =− 0.581, P = 0.002). Concentration of IL-6 was again
associated with gestational age (R = 0.462, P = 0.017)
and TNF-α (R = 0.424, P = 0.031). Baseline diameter was
inversely associated with hsCRP (R =− 0.459, P = 0.021).
Postpartum in the hypertensive pregnancies group
FMD% correlated negatively to baseline diameter (R =
−0.585, P = 0.017) and positively to TNF-α (R = 0.673,
P = 0.017). Dilation in nitro test was negatively associated to
baseline diameter (R =− 0.671, P = 0.006). Concentration
of hsCRP was associated with weight (R = 0.706, P = 0.010).
4. Discussion
The new ﬁnding of the present study was that brachial artery
FMD was not attenuated in women with mild to moderate4 ISRN Obstetrics and Gynecology
Table 2
(a) FMD during pregnancy and postpartum, data are expressed as means, (minimums, maximums) and standard deviations. Normal pregnancies
compared to hypertensive pregnancies
FMD (%) P
Pregnancy Postpartum
Control group (N = 32/24) 8.8 (−1.5–21) ± 5.1 7.9 (2.9–16) ± 3.5 P = 0.439
Hypertensive pregnancies (N = 26/16) 11 (−2.9–24) ± 6.3 8.0 (1.6–16) ± 4.2 P = 0.105
P P = 0.194 P = 0.978
(b) FMDinnormal,hypertensiveendpreeclampticwomenduringpregnancyandpostpartum.Themean,minimums,maximums,andstandarddeviations
Mean baseline diameter
of the a. brachialis in
pregnancy (mm)
Mean FMD during
pregnancy %
Mean FMD in
nitrotest during
pregnancy
Mean baseline
diameter of the a.
brachialis postpartum
(mm)
Mean FMD
postpartum %
Mean FMD
in nitro test
postpartum
Normal
pregnancy
(N = 32/24)
0.33 (0.27–0.43) ± 0.04 8.8% 22% 0.30 (0.25–0.38) ± 0.03 7.9% 26%
Hypertensive
pregnancy
(N = 14/9)
0.35 (0.30–0.45) ± 0.04 10% 19% 0.32 (0.29–0.36) ± 0.03 8.5% 26%
Preeclamptic
pregnancies
(N = 12/7)
0.31 (0.24–0.34) ± 0.03 11% 21% 0.30 (0.25–0.34) ± 0.04 7.2% 28%
Diﬀerence btw
the groups
HT versus PE
P = 0.008
NS/HT versus PE
P = 0.003 NS NS NS/NS NS
pregnancy
versus
postpartum
Control P<0.001, HT
P = 0.001, PE NS PE P = 0.04
Control
P = 0.005
HT P<0.001
PE P = 0.004
(c) FMD during pregnancy and postpartum. Means, minimums, and maximums and SDs
Pregnancy Postpartum P
Brachial artery diameter at
rest (cm)
Control (N = 32/24) 0.33 (0.27–0.43) ± 0.04 0.30 (0.25–0.38) ± 0.03 <0.001∗
Hypertensive (N = 26/16) 0.33 (0.24–0.45) ± 0.04 0.31 (0.25–0.36) ±0.03 0.011∗
P 0.988 0.534
Endothelium dependent
vasodilation, FMD% (%)
Control (N = 32/24) 8.8 (−1.5–21) ± 5.1 7.9 (2.9–16) ± 3.5 0.439
Hypertensive (N = 26/16) 11.0 (−2.9–24) ± 6.3 8.0 (1.6–16) ± 4.2 0.105
P 0.194 0.978
Endothelium independent
vasodilation, NTG (%)
Control (N = 32/24) 22% 26% 0.005∗
Hypertensive (N = 26/16) 20% 28% <0.001∗
P 0.221 0.421
∗: P value < 0.05.
preeclampsia and hypertension in pregnancy or postpartum.
In earlier studies endothelial dysfunction was present several
weeks before clinical manifestation of preeclampsia and also
several years after parturition in severe preeclampsia as
compared to normal pregnancies [10]. To our knowledge
there is only one previous study on the endothelial function
in present preeclampsia or pregnancy-related hypertension
[11].
The signiﬁcantly lower birth weight (3597 versus 2907
grams) can be explained with slightly earlier delivery 40
v e r s u s3 8w e e k si nn o r m a lv e r s u sh y p e r t e n s i v ep r e g n a n c i e s
and also with placental dysfunction in late pregnancy in hy-
pertensive pregnancies. Partly the diﬀerence was iatrogenic
as the policy was to induce the labour at the onset of pree-
clampsia. However, the preeclampsia group of women had
mild to moderate disease since in severe disease the protocol
of this study would have been too challenging and therefore
the diﬀerences between the birth weight and weeks at
delivery were not clinically relevant.
Koopman et al. investigated microvascular endothelial
function in women with intrauterine growth restriction
(IUGR) with Laser Doppler ﬂuxmetry using iontophoresis
of acethylcholine (ACh) and sodium nitroprusside, and their
ﬁnding was that endothelium-dependent (ACh-mediated)ISRN Obstetrics and Gynecology 5
Table 3: Concentrations of hsCRP, IL-6, and TNF-α during preg-
nancy and postpartum. Medians (minimum-maximum).
Pregnancy Postpartum P
hsCRP
(mg/L)
Control
N = 21/14
3.0
(0.54–13.4) 2.4 (0.22–7.0) 0.212
Hypertensive
N = 24/12 4.5 (0.89–38) 0.80 (0.27–5.9) 0.023∗
P 0.328 0.879
IL-6
(pg/mL)
Control
N = 21/14 1.8 (0.64–5.4) 1.3 (0.31–5.1) 0.118
Hypertensive
N = 24/12 2.1 (0.70–11) 1.2 (0.73–3.0) 0.006∗
P 0.137 0.879
TNF-α
(pg/mL)
Control
N = 21/14 2.0 (1.2–4.1) 1.8 (1.1–4.0) 0.451
Hypertensive
N = 24/12 1.9 (0.88–3.2) 1.5 (0.71–2.1) 0.030∗
P 0.595 0.101
∗: P value < 0.05.
vasodilation was signiﬁcantly increased in women with
IUGR [12]. The investigators hypothesised that constant
vasoconstriction in microcirculation of the IUGR mothers
was the reason to improved endothelial dilation with ACh,
indicating that endothelial dysfunction was behind the
increased dilation. In the present study we used other
methodology and probably the vascular bed also was diﬀer-
ent from that seen in IUGR, but this is the only study along
with the present study showing an increase in endothelium
dependent vasodilation not only in normal but also in
complicated late pregnancies. Based on our ﬁndings we
believe that the endothelial dysfunction that no doubt was
present in hypertensive, preeclamptic, and also in IUGR
pregnancieswasnotsimilartoendothelialdysfunctionfound
incardiovasculardiseasesandnotnecessarilyevendetectable
noninvasively in conduit arteries in late pregnancy.
Endothelial dysfunction has been previously shown to
be present in obese mothers (BMI > 30kg/m2) in all three
trimesters of pregnancy and four-month postpartum [13],
andalsoinheavysmokersinthethirdtrimesterofpregnancy
[14]. However, it is likely that the endothelial dysfunction in
these cases is related to the metabolic phenotype of these
women and not to the placental phenotype. On the other
hand, traditional risk factors do not have an eﬀect on endo-
thelial function during pregnancy, since we have shown in
a previous cohort study, that despite marked pregnancy-
related hyperlipidemia, endothelial function was improved
in healthy women and in normal pregnancies [4].
Our present work suggested that endothelial function
in conduit arteries is similar in normal and in hypertensive
pregnancies. In both groups endothelial function was better
during pregnancy than postpartum, and in hypertensive
pregnancies endothelial vasodilation after stimulus was
even better than in normal pregnancies. The endothelial
dysfunction in hypertensive pregnancies and in mild to
moderate preeclampsia was not detectable in the brachial
artery. It is possible that the increased blood ﬂow in hyper-
tensive pregnancies results in increased shear stress and thus
even to greater increase in shear-stress mediated increased
vasodilation. In a previous study, pulsed Doppler ﬁndings
of maternal uterine artery, maternal ophthalmic artery, and
brachial artery ﬂow-mediated vasodilation varied among
women with preeclampsia showing that there were vascular
changes concomitantly or separately in uterus, ophthalmic
vessels and conduit arteries [15]. In the microvascular
bed, the endothelial dysfunction is easily detectable and
the oedema caused by leaking endothelium could interfere
with the measurements. Most probably the compromised
nitric oxide production causing vasoconstriction is not the
only mechanism leading topregnancy-induced hypertension
or preeclampsia, as we found increased FMD also in late
hypertensive pregnancies.
We found that brachial artery diameter at rest had a neg-
ative correlation to FMD, because the small arteries dilate
more than the larger ones. In normal pregnancies, near-term
weight correlated also negatively to FMD. After hypertensive
pregnancies TNF-α had a positive correlation to FMD but
otherwise the correlations between proinﬂammatory cytok-
ines and FMD were poor.
In this longitudinal study we found that even in normal
pregnancies the third trimester concentrations of hsCRP, IL-
6, and TNF-α were increased as compared to the postpartum
values. The diﬀerence during pregnancy was not statistically
signiﬁcant between normal and hypertensive pregnancies
though we noticed an increase in hsCRP and IL-6 concentra-
t i o n si nh y p e r t e n s i v ep r e g n a n c i e s .T h i sn e g a t i v er e s u l tm a y
have occurred due to the type 2 error, meaning that sample
size was too small to conﬁrm the diﬀerence. From pregnancy
to 3-month postpartum all the investigated markers of
inﬂammation declined signiﬁcantly in hypertensive women.
The result veriﬁes that pregnancy-induced hypertension and
PE represent to some degree an inﬂammatory response to
the pregnancy. However, the markers of inﬂammation were
measured from systemic blood samples and thus the results
do not necessarily represent the concentrations in various
tissues as the cytokines are often released locally.
In conclusion, the present study showed that the endo-
thelial response to a hypertensive pregnancy measured by
FMD in the brachial artery was somewhat unexpected sug-
gesting rather improvement than attenuation in endothelial
function as compared to women with uncomplicated preg-
nancies. The present ﬁndings suggest that instead of endo-
thelial dysfunction in conduit arteries other mechanisms
related to systemic inﬂammation may play more important
roles in the pathogenesis of gestational hypertension and
mild-to-moderate preeclampsia.
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